$16.03
-0.90-5.32%
가까이에: Sep 18, 5:00 PM EST
$16.10
0.070.44%
시간외: 5:33 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 19
Arcturus Therapeutics Holdings Inc
ARCTNASDAQ
Arcturus Therapeutics Earnings & Forecasts
Arcturus Therapeutics (ARCT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Arcturus Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.03 | $-1.04 | $-0.82 | $-0.98 |
| Actual | $-0.84 | $-0.95 | $-1.03 | $-0.49 |
| Surprise | +18.4% | +8.65% | -25.6% | +50.0% |
| Revenue | ||||
| Estimate | $3.0M | $7.1M | $14.3M | $14.2M |
| Actual | $3.0M | $2.1M | $7.2M | $17.2M |
| Surprise | -1.38% | -70.8% | -49.8% | +21.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.66 | $-0.92 | $-0.89 | $-0.91 |
| Revenue | ||||
| Consensus | $8.1M | $5.7M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved